Cleared Traditional

K883726 - THYROID STIMULATING HORMONE (HTSH) IRMA NEONATAL

K883726 is an FDA 510(k) clearance for THYROID STIMULATING HORMONE (HTSH) IRMA..., manufactured by Immuchem Corp.. The device is a Class 2 Chemistry device with product code JLW cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K883726 · Immuchem Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1988
Decision
106d
Days
Class 2
Risk

K883726 is an FDA 510(k) clearance for the THYROID STIMULATING HORMONE (HTSH) IRMA NEONATAL. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Immuchem Corp. (Carson, US). The FDA issued a Cleared decision on December 15, 1988 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Immuchem Corp. devices

FDA 510(k) Submission Details - K883726

510(k) Number K883726 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1988
Decision Date December 15, 1988
Days to Decision 106 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 88d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JLW Device Classification - Class 2, Special Controls

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 202
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K883726.
TSH MICROASSAY
K890579 · Diamedix Corp. · Mar 1989
VENTREX COATED TUBE HIGH SENSITIVITY TSH
K885157 · Ventrex Laboratories, Inc. · Feb 1989
MODIFIED TSH IRMA KIT
K883742 · Pacific Biotech, Inc. · Jan 1989
DELFIA(TM) NEONATAL HTSH KIT
K881627 · Pharmacia, Inc. · Oct 1988
AMERLITE TSH ASSAY, LAN.0001/2001 240 & 144 KIT
K882907 · Amersham Corp. · Sep 1988
VENTREX COATED TUBE TSH
K883342 · Ventrex Laboratories, Inc. · Sep 1988